KGC
KINROSS GOLD CORPMarquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q3 2013 | 52Q | $4.85 | $29 | +488% |
| Maverick Capital re-entered | Q4 2020 | 23Q | $7.13 | $29 | +300% |
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $8.36 | $29 | +241% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $8.88 | $29 | +221% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $8.88 | $29 | +221% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $8.88 | $29 | +221% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $8.88 | $29 | +221% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $8.88 | $29 | +221% |
| Point72 Asset Management re-entered | Q2 2025(8Q snapshot) | 4Q | $14 | $29 | +108% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Fundamentals
XBRL · KINROSS GOLD CORPNot enough XBRL history to plot. KINROSS GOLD CORPhasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for KINROSS GOLD CORP — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KFORM 6-KJun 1, 2026
- 6-KFORM 6-KMay 26, 2026
- 6-KFORM 6-KApr 30, 2026
- 6-KFORM 6-KApr 29, 2026
- 6-KFORM 6-KApr 29, 2026
- 6-KFORM 6-KApr 29, 2026
- 6-KFORM 6-KApr 10, 2026
- 6-KFORM 6-KApr 1, 2026
- 6-KFORM 6-KMar 30, 2026
- 6-KFORM 6-KMar 30, 2026
- 6-KFORM 6-KMar 26, 2026
- 6-KFORM 6-KMar 19, 2026
- 6-KFORM 6-KFeb 18, 2026
- 6-KFORM 6-KFeb 18, 2026
- 6-KFORM 6-KFeb 18, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Maverick Capital | Q2 2026 | open | $28 | $29 | +2% |
| Point72 Asset Management | Q1 2026 | open | $34 | $29 | -15% |
| Point72 Asset Management | Q2 2025 | Q4 2025 | $14 | $25 | +86% |
| Bridgewater Associates | Q3 2024 | open | $8.86 | $29 | +226% |
| Citadel Advisors | Q3 2024 | open | $8.88 | $29 | +221% |
| Two Sigma Investments | Q3 2024 | open | $8.88 | $29 | +221% |
| D.E. Shaw | Q3 2024 | open | $8.88 | $29 | +221% |
| AQR Capital Management | Q3 2024 | open | $8.88 | $29 | +221% |
| Millennium Management | Q3 2024 | open | $8.88 | $29 | +221% |
| Renaissance Technologies | Q3 2024 | open | $8.36 | $29 | +241% |
| Maverick Capital | Q3 2023 | Q2 2024 | $4.80 | $7.70 | +60% |
| Bridgewater Associates | Q1 2021 | Q3 2022 | $6.70 | $3.29 | -51% |
| Maverick Capital | Q4 2020 | Q3 2021 | $7.13 | $5.49 | -23% |
| Bridgewater Associates | Q3 2013 | Q3 2020 | $4.85 | $7.67 | +58% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.